Angelman Syndrome @UNC

News & Announcements

Philpot, Zylka, and Roth labs identify drug candidate for Angelman syndrome (http://sfari.org/news-and-opinion/conference-news/2011/society-for-neuroscience-2011/researchers-identify-drug-candidate-for-angelman-syndrome)

Dr. Portia McCoy is awarded a grant from the Autism Science Foundation to study the role of UBE3A in the structural plasticity of synapses (http://www.autismsciencefoundation.org/what-we-fund/ASF-funded-research/current-grantees).

Joint Zylka and Philpot lab paper is cover article in the prestigious journal Trends in Neurosciences (http://www.cell.com/trends/neurosciences/abstract/S0166-2236%2811%2900056-7)

Ben Philpot, Angela Mabb and Matthew Judson explain connections between autism, Angelman syndrome and the UBE3A gene (https://sfari.org/news-and-opinion/viewpoint/2011/insights-for-autism-from-angelman-syndrome)

Jason Yi receives a postdoctoral fellowship from FAST to study Angelman syndrome (http://www.cureangelman.org/newsletter/newsletter_november2011.pdf)

Zylka lab postdoctoral fellow Ian King receives Angelman Syndrome Foundation fellowship for his research on the causes of Angelman syndrome (http://www.med.unc.edu/physiolo/news/zylka-lab-postdoc-ian-king-receives-angelman-syndrome-foundation-fellowship)

Zylka, Roth, and Philpot labs receive Simons Foundation grant to identify small molecule compounds for treating autism spectrum disorders (http://sfari.org/funding/grants/abstracts/small-molecule-compounds-for-treating-autism-spectrum-disorders)